Of note, the anti-tumour activity of HBD-2 (≥50 μM) was lower than that reported for other plant and human defensins, such as NaD1 (~2–7 μM) and HBD-3 (~10–20 μM) [10,36], as well as its own antimicrobial activities (~1–4 μM) [27,34,64]. This evidence concerns the gene MT-ND1 and neoplasm.